Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
BMC Public Health|June 23, 2021
Usability and acceptability of self-testing for hepatitis C virus infection among the general population in the Nile Delta region of EgyptElena Ivanova Reipold, Ahmed Farahat, Amira Elbeeh, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|February 20, 2019
Treatment of Chronic Hepatitis C Infection Among Egyptian Kidney Transplant Recipients: A Pilot StudyHanzada Mohamed El Maghrabi, Ahmed Yahia Elmowafy, Ahmed Farouk Donia, et al.
Journal of Medical Virology|June 15, 2018
Change in the hepatic profile of hepatitis C virus genotype 4-infected patients with compensated cirrhosis receiving ombitasvir, paritaprevir, and ritonavir plus ribavirin: A subanalysis of the AGATE-II studyImam Waked, Gamal Esmat, Rabab Fouad, et al.
Journal of Hepatology|May 5, 2015
Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4Wahid Doss, Gamal Shiha, Mohamed Hassany, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trialImam Waked, Gamal Shiha, Roula B Qaqish, et al.
Gut|April 19, 2018
Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in EgyptGamal Shiha, Gamal Esmat, Mohamed Hassany, et al.
Journal of Hepatology|February 24, 2019
Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global datasetJ Morgan Freiman, Jianing Wang, Philippa J Easterbrook, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 12, 2021
Development and multicenter validation of FIB-6: A novel, machine learning, simple bedside score to rule out liver cirrhosis and compensated advanced chronic liver disease in patients with chronic hepatitis CGamal Shiha, Reham Soliman, Nabiel N H Mikhail, et al.
Clinics and Research in Hepatology and Gastroenterology|April 11, 2022
Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic responseJessica Azzi, Céline Dorival, Carole Cagnot, et al.
The Lancet. Gastroenterology & Hepatology|November 12, 2020
Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north AfricaGamal Shiha, Khalid Alswat, Maryam Al Khatry, et al.
Pageof 4